Evidence map›Paper›PMID 21318020›Full record

ReviewInternational journal of environmental research and public health2011

Smoking related diseases: the central role of monoamine oxidase.

Francine Rendu, Katell Peoc'h, Ivan Berlin, Daniel Thomas, Jean-Marie Launay

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Design, synthesis, molecular modelling andRoyal Society open science · 2020
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bacoside A: Role in Cigarette Smoking Induced Changes in Brain.Evidence-based complementary and alternative medicine : eCAM · 2015
    Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Francine RenduUMRS 956 (Génétique, Pharmacologie et Physiopathologie des maladies cardiovasculaires), Faculté de Médecine Pitié-Salpétrière, Université Pierre et Marie Curie, 91 Bd de l'hôpital, 75634 Paris cedex 13, France. francine.rendu@upmc.fr
Katell Peoc'h
Ivan Berlin
Daniel Thomas
Jean-Marie Launay
Université Paris Cité · FRFondation pour l’innovation en Cadiométabolisme et Nutrition · FRInserm · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smoking is a major risk factor of morbidity and mortality. It is well established that monoamine oxidase (MAO) activity is decreased in smokers. Serotonin (5-HT), a major substrate for MAO that circulates as a reserve pool stored in platelets, is a marker of platelet activation. We recently reported that smoking durably modifies the platelet 5-HT/MAO system by inducing a demethylation of the MAO gene promoter resulting in high MAO protein concentration persisting more than ten years after quitting smoking. The present data enlarges the results to another MAO substrate, norepinephrine (NE), further confirming the central role of MAO in tobacco use-induced diseases. Thus, MAO could be a readily accessible and helpful marker in the risk evaluation of smoking-related diseases, from cardiovascular and pulmonary diseases to depression, anxiety and cancer. The present review implements the new finding of epigenetic regulation of MAO and suggests that smoking-induced MAO demethylation can be considered as a hallmark of smoking-related cancers similarly to other aberrant DNA methylations.

Indexed as

Epigenesis, GeneticAnxietyBiomarkersCardiovascular DiseasesDepressionHumansHydroxyindoleacetic AcidLung DiseasesMethoxyhydroxyphenylglycolMonoamine OxidaseNeoplasmsNorepinephrineRisk FactorsSerotoninSmoking3,4-dihydroxyphenylglycolBiomarkersHydroxyindoleacetic AcidMethoxyhydroxyphenylglycolMonoamine OxidaseNorepinephrineSerotonincancercardiovasculardepressionepigeneticmonoamine oxidasenorepinephrineplateletsserotoninsmoking

Identifiers

PMID21318020
PMCPMC3037066
OpenAlexW2148590250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.